06:16 AM EDT, 05/12/2025 (MT Newswires) -- Aurinia Pharmaceuticals ( AUPH ) reported a Q1 earnings Monday of $0.16 per diluted share, swinging from a loss of $0.07 a year earlier.

An analyst polled by FactSet expected EPS of $0.14.

Revenue for the quarter ended March 31 was $62.5 million, compared with $50.3 million a year earlier.

Analysts surveyed by FactSet expected $61.1 million.

For 2025, the company reiterated its total revenue guidance in the range of $250 million to $260 million. Analysts surveyed by FactSet expect $258.5 million.

Shares of the company rose 2.5% in recent premarket activity.

Price: 8.20, Change: +0.20, Percent Change: +2.50